Invention Grant
- Patent Title: Heterocyclic inhibitors of ATR kinase
-
Application No.: US17009428Application Date: 2020-09-01
-
Publication No.: US11434233B2Publication Date: 2022-09-06
- Inventor: Maria Emilia Di Francesco , Philip Jones , Christopher Lawrence Carroll , Jason Bryant Cross , Suyambu Kesava Vijayan Ramaswamy , Michael Garrett Johnson , Sarah Lively , David Lapointe
- Applicant: Board of Regents, The University of Texas System , ChemPartner Corporation
- Applicant Address: US TX Austin; US CA South San Francisco
- Assignee: Board of Regents, The University of Texas System,ChemPartner Corporation
- Current Assignee: Board of Regents, The University of Texas System,ChemPartner Corporation
- Current Assignee Address: US TX Austin; US CA South San Francisco
- Agent Dennis A. Bennett; Lauren L. Stevens; Cynthia Hathaway
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D413/04 ; C07D411/14 ; C07D471/04 ; C07D417/14 ; A61K45/06 ; A61P35/00
Abstract:
The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Public/Granted literature
- US20210047311A1 HETEROCYCLIC INHIBITORS OF ATR KINASE Public/Granted day:2021-02-18
Information query
